Holen Sie sich die Stockscreener-App
13.51
2.67%
-0.37
Handel nachbörslich:
13.52
0.010
+0.07%
Schlusskurs vom Vortag:
$13.88
Offen:
$13.67
24-Stunden-Volumen:
13.68M
Relative Volume:
1.17
Marktkapitalisierung:
$9.33B
Einnahmen:
$6.82B
Nettoeinkommen (Verlust:
$309.60M
KGV:
30.02
EPS:
0.45
Netto-Cashflow:
$747.20M
1W Leistung:
+0.37%
1M Leistung:
+3.37%
6M Leistung:
-38.56%
1J Leistung:
-35.76%
1-Tages-Spanne:
$13.40
$13.76
1-Wochen-Bereich:
$13.20
$14.42
52-Wochen-Spanne:
$11.82
$28.00
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Vergleichen Sie AVTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
13.51 | 9.33B | 6.82B | 309.60M | 747.20M | 0.45 |
|
ISRG
Intuitive Surgical Inc
|
534.71 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.95 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.80 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.41 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.48 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Avantor Inc (AVTR) Shares Up 3.23% on Jun 4 - GuruFocus
KeyBanc maintains overweight rating on Avantor stock amid catalysts By Investing.com - Investing.com South Africa
PH Adjuster Memory Market Detailed in New Research Report | Avantor Inc., Thermo Fisher Scientific - openPR.com
KeyBanc maintains overweight rating on Avantor stock amid catalysts - Investing.com
RAYMOND JAMES REITERATES OUTPERFORM RATING FOR AVANTOR STOCK By Investing.com - Investing.com India
Policy Uncertainty Pulled Down Avantor (AVTR) - Insider Monkey
RAYMOND JAMES REITERATES OUTPERFORM RATING FOR AVANTOR STOCK - Investing.com
Long Term Trading Analysis for (AVTR) - news.stocktradersdaily.com
Avantor’s SWOT analysis: stock faces headwinds amid leadership change By Investing.com - Investing.com South Africa
Avantor's SWOT analysis: stock faces headwinds amid leadership change - Investing.com Australia
Avantor’s SWOT analysis: stock faces headwinds amid leadership change - Investing.com
Avantor Board Member Makes $253K Stock Purchase - Nasdaq
Avantor (AVTR) Faces Neutral Rating with Potential Downside | AV - GuruFocus
Avantor (AVTR) Faces Neutral Rating with Potential Downside | AVTR Stock News - GuruFocus
Avantor Inc (AVTR) Stock Price Down 4.16% on May 21 - GuruFocus
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know - FinancialContent
(AVTR) Trading Advice - news.stocktradersdaily.com
Avantor CEO Michael Stubblefield to Speak at 2025 Bank of America Health Care Conference - MSN
Transcript : Avantor, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 08 - marketscreener.com
Avantor at RBC Healthcare Conference: Navigating Market Challenges By Investing.com - Investing.com India
Avantor at RBC Healthcare Conference: Navigating Market Challenges - Investing.com
Avantor CEO Michael Stubblefield to Step Down, Search for Successor Underway - MSN
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - GuruFocus
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference – Company Announcement - Financial Times
Is Avantor, Inc. (AVTR) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey
Avantor (AVTR) Sees Significant Stake Acquisition by UBS | AVTR Stock News - GuruFocus
Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price - simplywall.st
Avantor at BofA Conference: Strategic Insights Amid CEO Transition By Investing.com - Investing.com Nigeria
Avantor at BofA Conference: Strategic Insights Amid CEO Transition - Investing.com
Transcript : Avantor, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10 - marketscreener.com
Avantor adopts new executive severance policy By Investing.com - Investing.com South Africa
Avantor adopts new executive severance policy - Investing.com
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
AVTR Q1 Earnings Call: CEO Transition and Margin Focus Amid Weak Market Conditions - Yahoo Finance
Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Biopreservation Industry Worth $7.1 billion by 2029, with a CAGR of 9.8% - The Globe and Mail
Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors - PR Newswire
Is Avantor, Inc. (AVTR) One of the Best Falling Stocks to Buy According to Analysts? - Insider Monkey
Avantor's (NYSE:AVTR) Profits Appear To Have Quality Issues - Yahoo Finance
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference - BioSpace
Avantor® to Participate in Bank of America Securities 2025 Healt - GuruFocus
Exclusive: Avantor CEO Sets Stage for Strategic Updates at BofA Healthcare Conference - Stock Titan
Avantor in Radnor Is Losing Longtime CEO Michael Stubblefield - DELCO.Today
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avantor Inc-Aktie (AVTR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SUMME GREGORY L | Director |
May 22 '25 |
Buy |
12.65 |
20,000 |
253,000 |
70,000 |
| SUMME GREGORY L | Director |
May 07 '25 |
Buy |
12.00 |
25,000 |
300,000 |
50,000 |
| Massaro Joseph R | Director |
Apr 29 '25 |
Buy |
12.30 |
8,100 |
99,630 |
35,038 |
| SUMME GREGORY L | Director |
Apr 28 '25 |
Buy |
12.50 |
25,000 |
312,500 |
25,000 |
| Kang Lan | Director |
Apr 28 '25 |
Buy |
12.57 |
5,000 |
62,850 |
35,215 |
| Peacock Jonathan M | Director |
Apr 28 '25 |
Buy |
12.81 |
8,091 |
103,646 |
202,715 |
| Bramwell James | EVP Sales, Customer Excellence |
Feb 26 '25 |
Sale |
17.53 |
3,758 |
65,878 |
87,379 |
| Bramwell James | EVP Sales, Customer Excellence |
Feb 27 '25 |
Sale |
17.00 |
774 |
13,158 |
86,605 |
| Eck Steven W | SVP & Chief Accounting Officer |
Feb 26 '25 |
Sale |
17.53 |
4,907 |
86,020 |
40,604 |
| Eck Steven W | SVP & Chief Accounting Officer |
Feb 27 '25 |
Sale |
17.00 |
1,033 |
17,561 |
39,571 |
2.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):